Yu-Jie Xu
Sichuan University(CN)Guangzhou First People's Hospital(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer Mechanisms and Therapy, RNA modifications and cancer, Pancreatic and Hepatic Oncology Research, Cancer-related molecular mechanisms research
Most-Cited Works
- → Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma(2021)209 cited
- → Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial(2022)143 cited
- → Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma(2021)32 cited
- → Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness(2022)22 cited
- → A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma(2022)18 cited
- → Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma(2021)14 cited
- → Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro(2021)6 cited
- → Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer(2024)3 cited
- → Potassium voltage‑gated channel subfamily E member 4 facilitates the malignant progression of colon cancer by enhancing EGF containing fibulin extracellular matrix protein 2 expression(2023)2 cited
- → Adjusted gemcitabine plus S-1 regimen as first-line chemotherapy in unresectable advanced pancreatic cancer: a long-term survival case report(2025)1 cited